Insulin Chart
Insulin Chart
Insulin Chart
Brand Name/ Formulary Status/ Concentration Manufacturer Prandial or Correction (Rapid Acting) Novolog (F) Aspart 100 units/mL Novo Nordisk Type of Insulin Lispro Humalog (NF) Lilly 100 units/mL May Be Mixed With Onset Peak Duration Administration in Relation to Meals 5 to 10 minutes before meals 15 minutes before or immediately after meals 30 minutes before meals 30 minutes before meals 30 minutes before meals see below see below without regard to meals Appearance
NPH NPH
clear clear
Prandial or Correction (Short Acting) Novolin R (R) Regular Novo Nordisk Humulin R U-500 (F) Regular Lilly Humulin R (NF) Regular Lilly Basal (Intermediate Acting) Novolin N (F) NPH Novo Nordisk Humulin N (NF) NPH Lilly Basal (Long Acting) Lantus (F) Glargine Aventis
cloudy cloudy
100 units/mL
clear
Regarding formulary status, F means the product is on the formulary, NF means the product is not on the formulary, and R means that use is restricted. The subcutaneous administration of regular insulin for correction or scheduled prandial doses is restricted to the Diabetes Management Service. This product is still available for intravenous use. When combining insulin products in a single syringe, remember fast first, meaning that the rapid- or short-acting product should be drawn up first, followed by the intermediate-acting product. When mixing NPH with a rapid-acting product, follow the administration in relation to meals information for the specified product. Only insulins from the same manufacturer should be mixed (ie, Lilly products with Lilly products). The 500-units/mL concentration of regular insulin is prepared and dispensed by pharmacy services. Neither NovoLog Mix 70/30 nor Humalog Mix 75/25 contains NPH insulin. ***Mixed insulins cannot be obtained through the nonformulary process. Separate orders for basal and rapid acting insulin must be written.*** A coversion chart for 70/30 to insulin glargine or NPH can be found on the Clinical Order Forms Page or contact the Diabetes Management Service This reference is produced by MUSC Drug Information Services (November 2007). This reference has been reviewed and approved by the MUSC Diabetes Taskforce and the Pharmacy and Therapeutics Committee. Supporting literature is available upon request. www.musc.edu/pharmacyservices/medusepol/InsulinComparisonChart.pdf
Onset
Peak
Duration
Appearance
do not mix with other insulins do not mix with other insulins do not mix with other insulins do not mix with other insulins do not mix with other insulins
within 15 minutes of meal initiation 30 minutes before meals 30 minutes before meals 30 minutes before meals within 15 minutes of meal initiation
cloudy
Novolin 70/30 (NF)* Novo Nordisk Humulin 50/50 (NF)* Lilly Humulin 70/30 (NF)* Lilly Humalog 75/25 (NF)* Lilly
100 units/mL
cloudy
100 units/mL
cloudy
100 units/mL
cloudy
100 units/mL
cloudy
Regarding formulary status, F means the product is on the formulary, NF means the product is not on the formulary, and R means that use is restricted. The subcutaneous administration of regular insulin for correction or scheduled prandial doses is restricted to the Diabetes Management Service. This product is still available for intravenous use. When combining insulin products in a single syringe, remember fast first, meaning that the rapid- or short-acting product should be drawn up first, followed by the intermediate-acting product. When mixing NPH with a rapid- or short-acting product, follow the administration in relation to meals information for the specified product. Only insulins from the same manufacturer should be mixed (ie, Lilly products with Lilly products). The 500 units/mL concentration of regular insulin is prepared and dispensed by pharmacy services. Neither NovoLog Mix 70/30 nor Humalog Mix 75/25 contains NPH insulin. Unless dispense as written is specified by the physician, orders written for Humulin R or Humulin N will automatically be converted to Novolin R or Novolin N, respectively. ***Mixed insulins cannot be obtained through the nonformulary process. Separate orders for basal and rapid acting insulin must be written.*** A coversion chart for 70/30 to insulin glargine or NPH can be found on the Clinical Order Forms Page or contact the Diabetes Management Service This reference is produced by MUSC Drug Information Services (November 2007). This reference has been reviewed and approved by the MUSC Diabetes Taskforce and the Pharmacy and Therapeutics Committee. Supporting literature is available upon request. www.musc.edu/pharmacyservices/medusepol/InsulinComparisonChart.pdf